In the JNCCN Special Edition: NCCN Oncology Pharmacy & Policy (JNCCN 2011;9[Suppl 3]), an error appears in the article, “New Options for the Management of Castration-Resistant Prostate Cancer: A Case Perspective.” In the left column, first full paragraph on page S-18, the statement reading “In the phase III study of 512 patients, median overall survival was increased by 4.5 months in the treatment group” should have read “In the phase III study of 512 patients, median overall survival was increased by 4.1 months in the treatment group.”
The statement has been corrected in the JNCCN Special Edition: NCCN Oncology Pharmacy & Policy available online at JNCCN.org.
